1. Home
  2. PPSI vs EVAX Comparison

PPSI vs EVAX Comparison

Compare PPSI & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pioneer Power Solutions Inc.

PPSI

Pioneer Power Solutions Inc.

HOLD

Current Price

$4.74

Market Cap

51.4M

Sector

Industrials

ML Signal

HOLD

EVAX

Evaxion Biotech

HOLD

Current Price

$4.03

Market Cap

42.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PPSI
EVAX
Founded
2008
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.4M
42.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PPSI
EVAX
Price
$4.74
$4.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$12.00
$12.33
AVG Volume (30 Days)
240.3K
65.9K
Earning Date
11-13-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.86
N/A
Revenue
$31,751,000.00
$7,650,000.00
Revenue This Year
$26.84
$128.77
Revenue Next Year
$10.26
N/A
P/E Ratio
$1.64
N/A
Revenue Growth
105.82
132.17
52 Week Low
$2.25
$1.20
52 Week High
$5.70
$12.15

Technical Indicators

Market Signals
Indicator
PPSI
EVAX
Relative Strength Index (RSI) 52.33 33.45
Support Level $4.70 $4.11
Resistance Level $5.24 $4.85
Average True Range (ATR) 0.36 0.38
MACD -0.04 -0.08
Stochastic Oscillator 26.37 8.23

Price Performance

Historical Comparison
PPSI
EVAX

About PPSI Pioneer Power Solutions Inc.

Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

Share on Social Networks: